MLYS
MINERALYS (MLYS)
NASDAQ
$26.19+$0.58 (+2.26%)
Price as of Jun 23, 2026 6:15 PM EDT
  • $2.2B
    Market Cap
  • 81.12%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-132.0M
-21.69%
-168.6M
+139.59%
-70.4M
N/A
Depreciation and Amortization Expense
59,000
+37.21%
43,000
N/A
N/A
N/A
Total Operating Expenses
170.6M
-11.33%
192.4M
+127.27%
84.7M
N/A
Operating Profit
-170.6M
-11.33%
-192.4M
+127.27%
-84.7M
N/A
Interest Income
N/A
N/A
N/A
N/A
3,000
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
-100.00%
3,000
N/A
Total Nonoperating Income and Expense
16.0M
+9.32%
14.6M
+14.37%
12.8M
N/A
Income before Taxes
-170.6M
-11.33%
-192.4M
+127.27%
-84.7M
N/A
Income Taxes
0
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-154.7M
-13.02%
-177.8M
+147.31%
-71.9M
N/A
Net Income from Continuing Operations Applicable to Common
-154.7M
-13.02%
-177.8M
+147.31%
-71.9M
N/A
Basic EPS and Net Income
-2.29
-37.43%
-3.66
+83.92%
-1.99
N/A
Diluted EPS and Net Income
-2.29
-37.43%
-3.66
+83.92%
-1.99
N/A
Basic Weighted Average Shares
67.7M
+39.38%
48.5M
+34.13%
36.2M
N/A
Diluted Weighted Average Shares
67.7M
+39.38%
48.5M
+34.13%
36.2M
N/A
Balance Sheet
Cash and Cash Equivalents
172.9M
+51.56%
114.1M
+131.40%
49.3M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
172.9M
+51.56%
114.1M
+131.40%
49.3M
N/A
Total Current Assets
661.4M
+222.08%
205.4M
-17.56%
249.1M
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
38,000
-28.30%
53,000
N/A
N/A
N/A
Total Long-Term Assets
382,000
-23.45%
499,000
+878.43%
51,000
N/A
Total Assets
661.8M
+221.42%
205.9M
-18.17%
251.6M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
15.1M
+3.19%
14.6M
+39.73%
10.5M
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
Total Liabilities
15.1M
+3.19%
14.6M
+39.73%
10.5M
N/A
Retained Earnings
-457.2M
+51.12%
-302.5M
+142.58%
-124.7M
N/A
Total Stockholders Equity
646.7M
+238.13%
191.3M
-20.69%
241.2M
N/A
Total Shares Outstanding
81.5M
+63.66%
49.8M
+21.12%
41.1M
N/A
Cash Flow
Cash from Operating Activities
-142.4M
-14.37%
-166.3M
+104.89%
-81.2M
N/A
Capital Expenditures
15,000
-84.37%
96,000
N/A
N/A
N/A
Cash from Investing Activities
-389.8M
-439.04%
115.0M
+171.64%
-160.5M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
591.0M
+408.86%
116.1M
-42.86%
203.2M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-35.65%
-54.14%
-77.72%
N/A
N/A
N/A
Return on Equity
-36.91%
-55.12%
-82.24%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
43.76
+212.12%
14.02
N/A
N/A
N/A
Cash Ratio
11.44
+46.88%
7.79
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow